Yahoo

Mail

La bourse ferme dans 26 min

CAC 40
8 024,35
-15,77(-0,20 %)
Euro Stoxx 50
5 065,23
-3,86(-0,08 %)
Dow Jones
38 944,67
+58,50(+0,15 %)
EUR/USD
1,0815
-0,0079(-0,72 %)
Gold future
2 330,80
-60,10(-2,51 %)
Bitcoin EUR
65 954,99
-129,66(-0,20 %)

Sensei Biotherapeutics, Inc. (SNSE)

NasdaqGM - NasdaqGM Cours en temps réel. Devise en USD

Ajouter à la liste dynamique

0,6601

-0,0024

(-0,36 %)

À partir de 10:47AM EDT. Marché ouvert.

Détenteurs principaux

Effectif d’initiés

Transactions d’initiés

Devise en USD

Achat d’initiés au cours des 6 derniers mois	Titres	Trans.
Achats	0	0
Ventes	S.O.	0
Titres nets achetés (vendus)	0	0
Total des titres d’initiés détenus	8,65M	S.O.
% des titres nets acquis (vendus)	S.O.	S.O.

Achats institutionnels nets à partir du trimestre précédent jusqu’au dernier trimestre	Titres
Titres nets achetés (vendus)	S.O.
% de variation dans les titres institutionnels détenus	S.O.

Transactions d’initiés rapportées - Deux dernières années

Initié	Transaction	Type	Valeur	Date	Titres
CELEBI JOHN Chief Executive Officer	Purchase at price 0.85 per share.	Direct	425	11 sept. 2023	500
BRODER SAMUEL Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
RICKS THOMAS GREGORY Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirect	0	10 juil. 2023	4 466
VOJTA DENEEN Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
HOLMEN BOB Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
ENGLISH JESSIE Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
HUMER KRISTIAN Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
RINGO WILLIAM R Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juil. 2023	4 466
APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 1.58 per share.	Indirect	5 437 824	01 juin 2023	3 441 661
APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.60 - 1.61 per share.	Indirect	3 539	23 févr. 2023	2 200
CELEBI JOHN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2023	73 193
CELEBI JOHN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2023	73 193
COLGAN ERIN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2023	51 346
COLGAN ERIN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2023	51 346
GALLAGHER PATRICK STEPHEN Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2023	43 513
GALLAGHER PATRICK STEPHEN Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2023	43 513
VAN-DER HORST EDWARD Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2023	41 265
BRODER SAMUEL Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juin 2022	4 466
RICKS THOMAS GREGORY Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juin 2022	4 466
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirect	0	10 juin 2022	4 466
VOJTA DENEEN Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juin 2022	4 466
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juin 2022	4 466
HOLMEN BOB Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juin 2022	4 466
ENGLISH JESSIE Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juin 2022	4 466
HUMER KRISTIAN Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	10 juin 2022	4 466
RINGO WILLIAM R Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	08 mars 2022	18 933
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Indirect	3 850	02 mars 2022	1 203
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Indirect	3 850	02 mars 2022	1 203
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Direct	3 850	02 mars 2022	1 203
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.20 per share.	Direct	3 850	02 mars 2022	1 203
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.60 per share.	Indirect	9 000	01 mars 2022	2 500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.60 per share.	Direct	9 000	01 mars 2022	2 500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.65 per share.	Indirect	9 125	25 févr. 2022	2 500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.65 per share.	Indirect	9 125	25 févr. 2022	2 500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.63 - 3.80 per share.	Indirect	63 950	24 févr. 2022	17 500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.63 - 3.80 per share.	Indirect	63 950	24 févr. 2022	17 500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.97 - 4.17 per share.	Indirect	80 187	18 févr. 2022	19 949
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.97 - 4.17 per share.	Indirect	80 187	18 févr. 2022	19 949
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.18 - 4.25 per share.	Indirect	52 642	16 févr. 2022	12 551
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.18 - 4.25 per share.	Indirect	52 642	16 févr. 2022	12 551
PIERCE ROBERT HAMILTON Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2022	21 000
CELEBI JOHN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2022	53 900
COLGAN ERIN Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 févr. 2022	21 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.40 - 4.58 per share.	Indirect	77 900	11 févr. 2022	17 500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.40 - 4.58 per share.	Direct	77 900	11 févr. 2022	17 500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.33 - 4.65 per share.	Indirect	135 800	08 févr. 2022	30 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.33 - 4.65 per share.	Direct	135 800	08 févr. 2022	30 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.22 - 4.31 per share.	Indirect	63 849	28 janv. 2022	15 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.22 - 4.31 per share.	Direct	63 849	28 janv. 2022	15 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.62 - 4.86 per share.	Indirect	235 824	26 janv. 2022	50 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.62 - 4.86 per share.	Direct	235 824	26 janv. 2022	50 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.69 - 4.94 per share.	Indirect	228 529	24 janv. 2022	47 410
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.69 - 4.94 per share.	Direct	228 529	24 janv. 2022	47 410
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.97 - 5.17 per share.	Indirect	154 313	20 janv. 2022	30 244
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.97 - 5.17 per share.	Direct	154 313	20 janv. 2022	30 244
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.08 per share.	Indirect	50 800	18 janv. 2022	10 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.08 per share.	Direct	50 800	18 janv. 2022	10 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.99 - 5.13 per share.	Indirect	133 392	14 janv. 2022	26 172
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.99 - 5.13 per share.	Direct	133 392	14 janv. 2022	26 172
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.18 - 5.22 per share.	Indirect	104 212	12 janv. 2022	20 047
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.18 - 5.22 per share.	Direct	104 212	12 janv. 2022	20 047
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Indirect	52 800	10 janv. 2022	10 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Direct	52 800	10 janv. 2022	10 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.85 per share.	Indirect	5 466	30 déc. 2021	1 127
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.85 per share.	Direct	5 466	30 déc. 2021	1 127
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirect	343 620	29 déc. 2021	69 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Direct	343 620	29 déc. 2021	69 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Indirect	59 601	28 déc. 2021	11 288
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.28 per share.	Direct	59 601	28 déc. 2021	11 288
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.30 per share.	Indirect	19 674	27 déc. 2021	3 712
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.30 per share.	Direct	19 674	27 déc. 2021	3 712
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.27 per share.	Indirect	57 970	23 déc. 2021	11 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.27 per share.	Direct	57 970	23 déc. 2021	11 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.29 per share.	Indirect	619	17 déc. 2021	117
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.29 per share.	Direct	619	17 déc. 2021	117
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.25 per share.	Indirect	57 356	16 déc. 2021	10 925
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.25 per share.	Direct	57 356	16 déc. 2021	10 925
RICKS THOMAS GREGORY Director	Purchase at price 5.86 - 6.62 per share.	Indirect	249 600	10 déc. 2021	40 000
PIERCE ROBERT HAMILTON Officer	Sale at price 7.34 per share.	Indirect	117 718	11 août 2021	16 030
PIERCE ROBERT HAMILTON Officer	Sale at price 7.06 - 7.13 per share.	Indirect	568 246	10 août 2021	79 792
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirect	4 200	05 mai 2021	350
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Direct	4 200	05 mai 2021	350
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.77 per share.	Indirect	4 916	20 avr. 2021	385
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.77 per share.	Direct	4 916	20 avr. 2021	385
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.38 per share.	Indirect	26 292	19 avr. 2021	1 965
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.38 per share.	Direct	26 292	19 avr. 2021	1 965
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirect	28 000	13 avr. 2021	2 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Direct	28 000	13 avr. 2021	2 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirect	28 000	07 avr. 2021	2 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirect	28 000	07 avr. 2021	2 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirect	14 000	01 avr. 2021	1 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.00 per share.	Indirect	14 000	01 avr. 2021	1 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirect	24 000	30 mars 2021	2 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 12.00 per share.	Indirect	24 000	30 mars 2021	2 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 per share.	Indirect	52 950	24 mars 2021	3 750
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 per share.	Direct	52 950	24 mars 2021	3 750
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Indirect	143 400	23 mars 2021	10 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Indirect	136 230	23 mars 2021	9 500
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Direct	143 400	23 mars 2021	10 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.34 per share.	Direct	136 230	23 mars 2021	9 500
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.02 per share.	Indirect	32 789	22 mars 2021	2 183
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.02 per share.	Direct	32 789	22 mars 2021	2 183
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Indirect	12 459	18 mars 2021	817
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Direct	12 459	18 mars 2021	817
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Indirect	15 249	08 mars 2021	1 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.25 per share.	Direct	15 249	08 mars 2021	1 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.75 per share.	Indirect	110 000	05 mars 2021	8 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.75 per share.	Indirect	110 000	05 mars 2021	8 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 - 15.85 per share.	Indirect	75 800	04 mars 2021	5 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 14.12 - 15.85 per share.	Indirect	75 800	04 mars 2021	5 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirect	48 750	02 mars 2021	3 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirect	48 750	02 mars 2021	3 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirect	81 250	26 févr. 2021	5 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 16.25 per share.	Indirect	81 250	26 févr. 2021	5 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.79 - 18.42 per share.	Indirect	510 862	25 févr. 2021	31 000
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.79 - 18.42 per share.	Indirect	510 862	25 févr. 2021	31 000
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.04 - 18.10 per share.	Indirect	361 070	23 févr. 2021	20 300
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.04 - 18.10 per share.	Direct	361 070	23 févr. 2021	20 300
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.88 per share.	Indirect	185 062	22 févr. 2021	9 802
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 18.88 per share.	Indirect	185 062	22 févr. 2021	9 802
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.77 per share.	Indirect	233 009	19 févr. 2021	11 786
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.77 per share.	Indirect	233 009	19 févr. 2021	11 786
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Indirect	14 872	18 févr. 2021	753
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Indirect	14 852	18 févr. 2021	752
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Indirect	14 872	18 févr. 2021	753
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.75 per share.	Direct	14 852	18 févr. 2021	752
RICKS THOMAS GREGORY Director		Indirect		08 févr. 2021	301 769
H&S INVESTMENTS I L P Beneficial Owner of more than 10% of a Class of Security		Indirect		08 févr. 2021	4 361 835
PEYER JAMES Director and Beneficial Owner of more than 10% of a Class of Security		Indirect		08 févr. 2021	2 407 328
CAMBRIAN BIOPHARMA INC Beneficial Owner of more than 10% of a Class of Security		Indirect		08 févr. 2021	2 407 328

CAC 408 024,35-15,77(-0,20 %)

Euro Stoxx 505 065,23-3,86(-0,08 %)

Dow Jones38 944,67+58,50(+0,15 %)

EUR/USD1,0815-0,0079(-0,72 %)

Gold future2 330,80-60,10(-2,51 %)

Bitcoin EUR65 954,99-129,66(-0,20 %)

Sensei Biotherapeutics, Inc. (SNSE)

Transactions d’initiés

Transactions d’initiés rapportées - Deux dernières années

CAC 40
8 024,35
-15,77(-0,20 %)

Euro Stoxx 50
5 065,23
-3,86(-0,08 %)

Dow Jones
38 944,67
+58,50(+0,15 %)

EUR/USD
1,0815
-0,0079(-0,72 %)

Gold future
2 330,80
-60,10(-2,51 %)

Bitcoin EUR
65 954,99
-129,66(-0,20 %)